ID
37324
Description
Study ID: 111592 Clinical Study ID: 111592 Study Title: A Randomized, Double-blind, Placebo-controlled, Doseescalation Study to Assess the Anti-inflammatory Activity, Efficacy, and Safety of Intravenous SB-681323 in Subjects at Risk for Development of Acute Lung Injury or ARDS Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00996840 See https://clinicaltrials.gov/ct2/show/NCT00996840 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Placebo, SB-681323 Trade Name: N/A Study Indication: Lung Injury, Acute The primary objective of this phase 2 trial is to evaluate the safety and tolerability of intravenous dilmapimod/SB-681323 given in escalating dosages and over different intervals for three days in trauma patients at risk for the development of ALI or ARDS. This study consists of Screening, infusion of dilmapimod/SB-681323 on days 1-3, examination/sampling up to early day 5 (denoted as "Day 3 - 48 hrs") and a Follow-up on day 7. There are four cohorts, cohorts 1 and 3 receive the medication (or placebo) infusion over 4 hours, cohorts 2 and 4 over 24 hours. This 12 lead ECG form is to be completed at Screening, Day 2/3/4 at 0 hrs for all cohorts (Day 4 0 hrs denoted as Day 3 24 hrs), Follow-Up and for any repeat/unscheduled ECGs.
Lien
https://clinicaltrials.gov/ct2/show/NCT00996840
Mots-clés
Versions (1)
- 17/07/2019 17/07/2019 -
Détendeur de droits
GlaxoSmithKline
Téléchargé le
17 juillet 2019
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
SB-681323 in ALI/ARDS risk patients - NCT00996840
12 Lead ECG
- StudyEvent: ODM
Description
Dosing Date and Time
Alias
- UMLS CUI-1
- C3897500
- UMLS CUI-2
- C3469597
- UMLS CUI-3
- C0304229
Description
ECG
Alias
- UMLS CUI-1
- C1623258
Description
only applicable for scheduled ECGs on Day 2 (0 hrs) and Day 3 (0 hrs, 24 hrs)
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0439564
- UMLS CUI [1,2]
- C0687676
- UMLS CUI [1,3]
- C3897500
- UMLS CUI [1,4]
- C3469597
- UMLS CUI [1,5]
- C0304229
Description
ECG Date / Time
Type de données
datetime
Alias
- UMLS CUI [1]
- C2826846
Description
Heart Rate
Type de données
integer
Unités de mesure
- beats/min
Alias
- UMLS CUI [1]
- C0018810
Description
PR Interval
Type de données
float
Unités de mesure
- msec
Alias
- UMLS CUI [1]
- C0429087
Description
QRS Duration
Type de données
float
Unités de mesure
- msec
Alias
- UMLS CUI [1]
- C0429025
Description
Uncorrected QT Interval
Type de données
float
Unités de mesure
- msec
Alias
- UMLS CUI [1,1]
- C1287082
- UMLS CUI [1,2]
- C4072785
Description
If Machine -> record the QTC values(s) generated by the machine (QTcF/QTcB) If Manual -> record the RR interval that precedes the measured QT interval
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0855331
- UMLS CUI [1,2]
- C2911685
Description
if applicable
Type de données
float
Unités de mesure
- msec
Alias
- UMLS CUI [1,1]
- C1882512
- UMLS CUI [1,2]
- C0855331
Description
if applicable
Type de données
float
Unités de mesure
- msec
Alias
- UMLS CUI [1,1]
- C0855331
- UMLS CUI [1,2]
- C1882513
Description
if applicable
Type de données
float
Unités de mesure
- msec
Alias
- UMLS CUI [1,1]
- C0489636
- UMLS CUI [1,2]
- C0332152
- UMLS CUI [1,3]
- C0855331
Description
if 3 = Abnormal - Clinically significant: complete the ECG abnormality form for all clinically significant abnormalities, and additionally complete the AE form if the abnormality meets the protocol definition for an AE
Type de données
integer
Alias
- UMLS CUI [1]
- C0438154
Similar models
12 Lead ECG
- StudyEvent: ODM
C3469597 (UMLS CUI-2)
C0304229 (UMLS CUI-3)
C3469597 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,3])
C0687676 (UMLS CUI [1,2])
C3897500 (UMLS CUI [1,3])
C3469597 (UMLS CUI [1,4])
C0304229 (UMLS CUI [1,5])
C4072785 (UMLS CUI [1,2])
C2911685 (UMLS CUI [1,2])
C0855331 (UMLS CUI [1,2])
C1882513 (UMLS CUI [1,2])
C0332152 (UMLS CUI [1,2])
C0855331 (UMLS CUI [1,3])
Aucun commentaire